Michael Schaeffer
Director/Board Member presso VIVORYON THERAPEUTICS N.V.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Dr. Michael Schaeffer is an Executive Director & Chief Business Officer at Vivoryon Therapeutics NV.
He is on the Board of Directors at Vivoryon Therapeutics NV.
Dr. Schaeffer was previously employed as a Chief Executive Officer & Managing Director by Crelux GmbH and a Chief Executive Officer & Managing Director by SiREEN AG.
He received his doctorate degree from Ludwig-Maximilians-Universität München.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 04/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Michael Schaeffer
| Società | Posizione | Inizio |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Director/Board Member | - |
Precedenti posizioni note di Michael Schaeffer
| Società | Posizione | Fine |
|---|---|---|
Crelux GmbH
 Crelux GmbH BiotechnologyHealth Technology Crelux GmbH provides structure based drug discovery solutions. The firm provides customized services to support hit-finding, conformational analysis and lead optimization, including protein production, biophysical assays, fragment screening, and X-ray crystallography. It works for pharma, biotech and research organizations. The company was founded by Ismail Moarefi, Martin Ried and Michael Schaeffer and is headquartered in Martinsried, Germany. | Chief Executive Officer | 01/03/2016 |
| SiREEN AG | Chief Executive Officer | 01/01/2004 |
Formazione di Michael Schaeffer
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VIVORYON THERAPEUTICS N.V. | Health Technology |
| Aziende private | 2 |
|---|---|
| SiREEN AG | Commercial Services |
Crelux GmbH
Crelux GmbH BiotechnologyHealth Technology Crelux GmbH provides structure based drug discovery solutions. The firm provides customized services to support hit-finding, conformational analysis and lead optimization, including protein production, biophysical assays, fragment screening, and X-ray crystallography. It works for pharma, biotech and research organizations. The company was founded by Ismail Moarefi, Martin Ried and Michael Schaeffer and is headquartered in Martinsried, Germany. | Health Technology |
- Borsa valori
- Insiders
- Michael Schaeffer
